$538.00
Apalutamide 60 mg is a next-generation androgen receptor inhibitor used in Australia for the treatment of castration-resistant prostate cancer (CRPC). Apnat 60 mg helps delay disease progression in men with non-metastatic or metastatic prostate cancer.
| Active Ingredient (Generic Name): | Apalutamide |
|---|---|
| Indication: | Prostate cancer |
| Manufacturer: | Natco Pharma Ltd. |
| Packaging: | 120 tablets in 1 bottle |
| Strength | 60mg |
| Delivery Time: | 6 To 15 days |
| Tablet | 120 Tablet/s, 240 Tablet/s, 360 Tablet/s |
Related products
